Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMar 14, 2017 2:30 pm

Avino Silver & Gold Mines Ltd. (NSYE: ASM) Starts Presentation at 29th Annual ROTH Conference

Avino Silver & Gold Mines (NYSE: ASM) is engaged in the production and sale of silver, gold and copper bulk concentrates, as well as in the exploration, evaluation and acquisition of mineral properties. The company owns 42 mineral claims and leases four mineral claims in the state of Durango, Mexico. It also holds 100% interests in the Bralorne mine located in the Lillooet mining division, British Columbia, Canada; and the Eagle property located in the Mayo mining division of Yukon, Canada. Avino Silver & Gold Mines Ltd. was founded in 1968 and is headquartered in Vancouver, Canada. For more information,…

Continue Reading

TuesdayMar 14, 2017 2:30 pm

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) Starts Presentation at 29th Annual ROTH Conference

Concert Pharmaceuticals (NASDAQ: CNCE) is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The company’s approach starts with approved drugs in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting pulmonary diseases, including cystic fibrosis, central nervous systems (CNS) disorders, as well as autoimmune and inflammatory diseases. For more information, visit the company’s website www.concertpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication…

Continue Reading

TuesdayMar 14, 2017 2:30 pm

Tilly’s, Inc. (NYSE: TLYS) Starts Presentation at 29th Annual Roth Conference

Tilly's (NYSE: TLYS) retails casual apparel, footwear and accessories for young men and women, and boys and girls the United States. Its apparel merchandise includes tops, outerwear, bottoms, and dresses; and accessories merchandise comprises backpacks, hats, sunglasses, headphones, handbags, watches, jewelry, and others. The company also provides third-party merchandise assortment in its apparel, accessory, and footwear product categories. As of January 30, 2016, Tilly’s operated 224 stores in 32 states. The company also sells its products through its e-commerce website, tillys.com. For more information, visit the company’s website at www.tillys.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

Continue Reading

TuesdayMar 14, 2017 2:30 pm

MINDBODY, Inc. (NASDAQ: MB) Starts Presentation at 29th Annual Roth Conference

MINDBODY (NASDAQ: MB) operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build client scheduling and online booking, staff management, client relationship management, integrated software and payments, retail point-of-sale, analytics and reporting, simple and intuitive user experience, mobility, social integration, cloud-based architecture, open platform for third-party application development, security and compliance, and integration with other cloud-based partners for yoga, Pilates, barre, indoor cycling, personal training, martial arts, and dance exercise, spas, salons, music instruction studios, dance studios, children’s activity centers, and…

Continue Reading

TuesdayMar 14, 2017 2:30 pm

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Starts Presentation at 29th Annual Roth Conference

Xenetic Biosciences (NASDAQ: XBIO) is a clinical-stage biopharmaceutical company that focuses on the discovery, development and planned commercialization of human drug therapies for the treatment of various conditions. Its drug delivery platform systems include PolyXen for creating next generation biologic drugs; OncoHist for the development of oncology drugs focused on orphan indications; Virexxa for the treatment of progesterone receptor negative endometrial cancer; and ImuXen for the development of vaccines that can simultaneously deliver multiple active pharmaceutical ingredients. Its product candidates comprise ErepoXen, a polysialylated erythropoietin for the treatment of anemia in pre-dialysis patients with chronic kidney disease; and OncoHist, an…

Continue Reading

TuesdayMar 14, 2017 2:00 pm

Cytori Therapeutics, Inc. (NASDAQ: CYTX) Starts Presentation at 29th Annual ROTH Conference

Cytori Therapeutics (NASDAQ: CYTX) develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy. For more information, visit the company’s website at www.cytori.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

TuesdayMar 14, 2017 2:00 pm

Unique Fabricating, Inc. (NYSE: UFAB) Starts Presentation at 29th Annual Roth Conference

Unique Fabricating (NYSE: UFAB) engineers and manufactures multi-material foam, rubber, and plastic components utilized in noise, vibration, and harshness (NVH), acoustical management, water and air sealing, decorative, and other functional applications. It supplies die cut non-metallic materials and components, which are used in applications, such as air and water sealing, insulation, NVH performance, and BSR conditions; thermoformed and compression molded products, including HVAC air ducts, door watershields, evaporator liners, console bin mats, fender insulators, and others; and fusion molded products comprising exterior mirror seals, cowl-to-hood seals, cowl-to-fender seals, and other products for NVH management and body sealing applications. For more…

Continue Reading

TuesdayMar 14, 2017 2:00 pm

Coeur Mining, Inc. (NYSE: CDE) Starts Presentation at 29th Annual ROTH Conference

Coeur Mining (NYSE: CDE) is a diversified precious metals producer with five precious metals mines in the Americas employing approximately 2,000 people. Coeur produces from its wholly owned operations: the Palmarejo silver-gold complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, the Wharf gold mine in South Dakota, and the San Bartolomé silver mine in Bolivia. The company also has a non-operating interest in the Endeavor mine in Australia. In addition, the company has two silver-gold exploration stage projects - the La Preciosa project in Mexico and the Joaquin project in Argentina. Coeur conducts…

Continue Reading

TuesdayMar 14, 2017 2:00 pm

Asure Software, Inc. (NASDAQ: ASUR) Starts Presentation at 29th Annual ROTH Conference

Asure Software (NASDAQ: ASUR), headquartered in Austin, Texas, offers intuitive and innovative technologies that enable companies of all sizes and complexities to operate more efficiently. The company ensures a high-performing work environment by integrating its “keep it simple” solutions and expertise to more than 7,000 clients worldwide. Asure Software’s suite of solutions range from HCM workforce management solutions, time and attendance to workspace asset optimization and meeting room management solutions. For more information, visit the company’s website at www.asuresoftware.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

Continue Reading

TuesdayMar 14, 2017 2:00 pm

BioSpecifics Technologies Corp. (NASDAQ: BSTC) Starts Presentation at 29th Annual ROTH Conference

BioSpecifics Technologies (NASDAQ: BSTC) is a biopharmaceutical company that engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. BioSpecifics is also involved in the development of other clinical indications for which collagenase…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000